BRPI0818893A2 - TROPANE COMPOUNDS - Google Patents
TROPANE COMPOUNDSInfo
- Publication number
- BRPI0818893A2 BRPI0818893A2 BRPI0818893A BRPI0818893A2 BR PI0818893 A2 BRPI0818893 A2 BR PI0818893A2 BR PI0818893 A BRPI0818893 A BR PI0818893A BR PI0818893 A2 BRPI0818893 A2 BR PI0818893A2
- Authority
- BR
- Brazil
- Prior art keywords
- tropane compounds
- tropane
- compounds
- formula
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
Abstract
A compound according to Formula I or II: wherein R1, R1b, R2, L1, and L2 and L2b are as defined in the specification, pharmaceutical compositions thereof, and methods of use thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68707P | 2007-10-25 | 2007-10-25 | |
US61/000,687 | 2007-10-25 | ||
PCT/US2008/012221 WO2009055077A1 (en) | 2007-10-25 | 2008-10-27 | Tropane compounds |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0818893A2 true BRPI0818893A2 (en) | 2015-05-05 |
BRPI0818893B1 BRPI0818893B1 (en) | 2021-02-02 |
BRPI0818893B8 BRPI0818893B8 (en) | 2021-05-25 |
Family
ID=40287869
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0818893A BRPI0818893B8 (en) | 2007-10-25 | 2008-10-27 | tropane compounds, their pharmaceutical compositions, their uses and in vitro method of inhibiting hsp90 in a cell |
Country Status (27)
Country | Link |
---|---|
US (1) | US8012956B2 (en) |
EP (1) | EP2074120B1 (en) |
JP (2) | JP5476307B2 (en) |
KR (1) | KR101578792B1 (en) |
CN (1) | CN101910168B (en) |
AT (1) | ATE459622T1 (en) |
AU (1) | AU2008317262B2 (en) |
BR (1) | BRPI0818893B8 (en) |
CA (1) | CA2703477C (en) |
CO (1) | CO6321232A2 (en) |
CY (1) | CY1110648T1 (en) |
DE (1) | DE602008000754D1 (en) |
DK (1) | DK2074120T3 (en) |
EA (1) | EA018999B1 (en) |
ES (1) | ES2342348T3 (en) |
HK (1) | HK1129390A1 (en) |
HR (1) | HRP20100292T1 (en) |
IL (1) | IL205202A0 (en) |
MX (1) | MX2010004493A (en) |
NZ (1) | NZ585137A (en) |
PL (1) | PL2074120T3 (en) |
PT (1) | PT2074120E (en) |
RS (1) | RS51346B (en) |
SG (1) | SG2012079653A (en) |
SI (1) | SI2074120T1 (en) |
WO (1) | WO2009055077A1 (en) |
ZA (1) | ZA201002987B (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2553340T3 (en) * | 2007-12-12 | 2015-12-07 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
FR2949467B1 (en) | 2009-09-03 | 2011-11-25 | Sanofi Aventis | NOVEL 5,6,7,8-TETRAHYDROINDOLIZINE DERIVATIVES INHIBITORS OF HSP90, COMPOSITIONS CONTAINING SAME AND USE THEREOF |
UY32940A (en) | 2009-10-27 | 2011-05-31 | Bayer Cropscience Ag | AMIDAS REPLACED WITH HALOGENO RENT AS INSECTICIDES AND ACARICIDES |
MX2012011521A (en) | 2010-04-05 | 2013-03-08 | Shionogi & Co | Cephem compound having catechol group. |
WO2012068096A2 (en) | 2010-11-15 | 2012-05-24 | Exelixis, Inc. | Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture |
EP2740474A1 (en) | 2012-12-05 | 2014-06-11 | Instituto Europeo di Oncologia S.r.l. | Cyclopropylamine derivatives useful as inhibitors of histone demethylases kdm1a |
US20150352086A1 (en) * | 2013-01-07 | 2015-12-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Heat shock protein (hsp) inhibition and monitoring effectiveness thereof |
JP6485817B2 (en) | 2013-08-21 | 2019-03-20 | ヤンセン バイオファーマ インク. | Antiviral compound |
MX2016006457A (en) * | 2013-11-18 | 2017-01-06 | Del Mar Pharmaceuticals | Hplc analysis of impurities in dianhydrogalactitol. |
EP2949648A1 (en) | 2014-05-30 | 2015-12-02 | IEO - Istituto Europeo di Oncologia Srl | Cyclopropylamine derivatives as histone demethylase inhibitors |
US10233165B2 (en) | 2014-05-30 | 2019-03-19 | Istituto Europeo Di Oncologia S.R.L. | Cyclopropylamine compounds as histone demethylase inhibitors |
US20170224670A1 (en) | 2014-10-14 | 2017-08-10 | Exelixis, Inc. | Drug Combination to Treat Melanoma |
KR20180025907A (en) * | 2015-07-16 | 2018-03-09 | 아쿠루 파마 아베 | Detection and treatment of renal cell carcinoma with SLC6A3 linked to label, cytotoxic or immunomodulatory group |
EP3588064B1 (en) * | 2017-02-23 | 2022-09-07 | IHI Corporation | Oh radical detection probe, oh radical measurement device, and oh radical measurement method |
CN108164529B (en) * | 2017-12-25 | 2020-04-24 | 三峡大学 | Small molecule inhibitor SLD9059 and application thereof in pharmacy |
US11466012B2 (en) | 2018-01-10 | 2022-10-11 | Allinky Biopharma | Tetrahydroisoquinoline compounds |
CN111825702A (en) * | 2019-04-22 | 2020-10-27 | 成都科岭源医药技术有限公司 | Aza indazole derivative and preparation method and application thereof |
CN110698395B (en) * | 2019-10-22 | 2021-05-25 | 杭州百诚医药科技股份有限公司 | Preparation method of topiroxostat intermediate |
CN112920078A (en) * | 2019-12-05 | 2021-06-08 | 武汉珈汇精化科技有限公司 | Method for preparing 4-cyanobenzoic acid methyl ester and method for preparing 4-cyanobenzoic acid |
TW202136238A (en) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | ROR[gamma]T inhibitor, preparation method therefor and use thereof |
IL302081A (en) * | 2020-10-14 | 2023-06-01 | Ranok Therapeutics Hangzhou Co Ltd | Methods and compositions for targeted protein degradation |
WO2022132679A1 (en) * | 2020-12-18 | 2022-06-23 | Merck Sharp & Dohme Corp. | Amido-substituted pyridyl compounds and methods of use thereof for the treatment of herpesviruses |
CN112707809B (en) * | 2020-12-30 | 2023-08-29 | 丽珠集团新北江制药股份有限公司 | Method for preparing oxazoline insecticide fluorine Lei Lana intermediate |
CN117729914A (en) * | 2021-07-26 | 2024-03-19 | 硕腾服务有限责任公司 | Serotonin 5-HT2B inhibiting compounds |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0101641A3 (en) | 1982-07-22 | 1984-03-28 | Beecham Group Plc | Sulfonylamino-aza-bicyclo-alkyl derivatives |
FR2738569B1 (en) | 1995-09-12 | 1997-11-28 | Pf Medicament | NOVEL NAPHTAMIDE DERIVATIVES OF 3 BETA-AMINO AZABICYCLO OCTANE OR NONANE, THEIR PREPARATION METHOD, THEIR USE AS ANTIPSYCHOTIC DRUGS |
PT876366E (en) | 1996-01-15 | 2002-01-30 | Janssen Pharmaceutica Nv | ANGIOGENESE INHIBITOR PYRIDAZINAMINS |
HUP0202001A2 (en) * | 2002-06-14 | 2005-08-29 | Sanofi-Aventis | Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity |
US7358244B2 (en) | 2003-05-28 | 2008-04-15 | Theravance, Inc. | Azabicycloalkane compounds |
EP1638965A1 (en) * | 2003-06-24 | 2006-03-29 | NeuroSearch A/S | Novel 8-aza-bicyclo¬3.2.1|octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
RS20060198A (en) | 2003-10-03 | 2008-09-29 | Pfizer Limited, | Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activ ity for the treatment of hiv and inflammation |
GB0323236D0 (en) * | 2003-10-03 | 2003-11-05 | Pfizer Ltd | Chemical compounds |
DK1731518T3 (en) * | 2004-03-31 | 2014-09-29 | Nippon Soda Co | CYCLIC AMINE COMPOSITION AND PESTICIDES |
FR2873693B1 (en) * | 2004-07-29 | 2006-09-15 | Sanofi Synthelabo | AMINO-TROPANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
JP2008526923A (en) | 2005-01-13 | 2008-07-24 | ノイロサーチ アクティーゼルスカブ | Novel 8-substituted 8-aza-bicyclo [3.2.1] octane derivatives and their use as monoamine neurotransmitter reuptake inhibitors |
EP2251341A1 (en) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
KR101006363B1 (en) * | 2005-10-06 | 2011-01-10 | 닛뽕소다 가부시키가이샤 | Cross-linkend cyclic amine compounds and agents for pest control |
ATE550334T1 (en) * | 2006-09-01 | 2012-04-15 | Otsuka Agritechno Co Ltd | N-PYRIDYLPIPERIDINE COMPOUND, METHOD FOR PRODUCING THEREOF AND PEST CONTROL AGENT |
-
2008
- 2008-10-27 EP EP08832769A patent/EP2074120B1/en active Active
- 2008-10-27 NZ NZ585137A patent/NZ585137A/en unknown
- 2008-10-27 CN CN200880122860.5A patent/CN101910168B/en active Active
- 2008-10-27 JP JP2010531069A patent/JP5476307B2/en active Active
- 2008-10-27 MX MX2010004493A patent/MX2010004493A/en active IP Right Grant
- 2008-10-27 PL PL08832769T patent/PL2074120T3/en unknown
- 2008-10-27 SG SG2012079653A patent/SG2012079653A/en unknown
- 2008-10-27 AT AT08832769T patent/ATE459622T1/en active
- 2008-10-27 CA CA2703477A patent/CA2703477C/en active Active
- 2008-10-27 AU AU2008317262A patent/AU2008317262B2/en active Active
- 2008-10-27 DK DK08832769.7T patent/DK2074120T3/en active
- 2008-10-27 RS RSP-2010/0220A patent/RS51346B/en unknown
- 2008-10-27 ES ES08832769T patent/ES2342348T3/en active Active
- 2008-10-27 EA EA201070519A patent/EA018999B1/en not_active IP Right Cessation
- 2008-10-27 WO PCT/US2008/012221 patent/WO2009055077A1/en active Application Filing
- 2008-10-27 US US12/290,159 patent/US8012956B2/en active Active
- 2008-10-27 KR KR1020107011444A patent/KR101578792B1/en not_active Application Discontinuation
- 2008-10-27 BR BRPI0818893A patent/BRPI0818893B8/en active IP Right Grant
- 2008-10-27 SI SI200830024T patent/SI2074120T1/en unknown
- 2008-10-27 DE DE602008000754T patent/DE602008000754D1/en active Active
- 2008-10-27 PT PT08832769T patent/PT2074120E/en unknown
-
2009
- 2009-10-09 HK HK09109388.2A patent/HK1129390A1/en unknown
-
2010
- 2010-04-19 IL IL205202A patent/IL205202A0/en active IP Right Grant
- 2010-04-29 ZA ZA2010/02987A patent/ZA201002987B/en unknown
- 2010-05-24 CO CO10061824A patent/CO6321232A2/en not_active Application Discontinuation
- 2010-05-24 HR HR20100292T patent/HRP20100292T1/en unknown
- 2010-06-01 CY CY20101100483T patent/CY1110648T1/en unknown
-
2013
- 2013-12-13 JP JP2013257559A patent/JP5745021B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE459622T1 (en) | TROPANE COMPOUNDS | |
EA201100037A1 (en) | ORGANIC COMPOUNDS | |
CY1118199T1 (en) | SUBJECTS OF SUBSTITUTED TYRAZOLO [1,5] PYRIMIDINE AS INTERMEDIATE IN THE TRK COMPOSITION COMPOSITION | |
EA201270254A1 (en) | DERIVATIVES OF 5-FLUOROPYRIMIDINON | |
EA201070786A1 (en) | BENZOFUROPYRIMIDINONES | |
UA107445C2 (en) | LibreOfficeDERIVATIVES AS FUNGICIDES | |
SMAP201100019A (en) | Organic compounds. | |
EA201201377A1 (en) | DEFINED AMINOPIRIDAZINES, COMPOSITIONS ON THEIR BASIS AND METHODS OF THEIR USE | |
BR112012018345A2 (en) | "heteroaryl compounds, as well as compositions and uses thereof" | |
MA32383B1 (en) | Indazole derivatives with phenyl and benzodoxynil alternatives | |
WO2010003133A3 (en) | Cdk modulators | |
RS53301B (en) | Thioacetate compounds, compositions and methods of use | |
EA201270257A1 (en) | DERIVATIVES N1-SULFONIL-5-FTORPYRIMIDINONA | |
EA201170884A1 (en) | DERIVATIVES OF PIPERIDINE, SUITABLE AS ANTAGONISTS OF OREXIN | |
UA108101C2 (en) | N3-substituted N1-sulfonyl-5-fluoropyrimidinone derivatives | |
NO20085317L (en) | Imidazoazepinonforbindelser | |
UA106889C2 (en) | N1-ACYL-5-FLORPYRIMIDINONE DERIVATIVES | |
ATE481395T1 (en) | CYCLOHEXYL DERIVATIVES | |
ATE533477T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING IRBESARTAN | |
RS53747B1 (en) | Phenanthrenone compounds, compositions and methods | |
UY30235A1 (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE | |
NZ590367A (en) | 9-Substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials | |
EA200702590A1 (en) | INHIBITORS OF SOLUBLE ADENYLACYCLIC | |
DOP2007000059A (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE | |
UY30237A1 (en) | INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/02/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 27/10/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |